Gut bacteria may boost cancer immunotherapy: new trial launches
NCT ID NCT04264975
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how gut bacteria affect immunotherapy in people with advanced solid tumors. It has two parts: first, finding bacterial markers linked to treatment response; second, testing if fecal transplants from healthy donors can make immunotherapy work better. About 60 adults with solid cancers who are on or about to start immunotherapy will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Asan Medical Center
RECRUITINGSeoul, Seoul, 05505, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Dual-Action antibody outsmart advanced solid tumors?
- Can a tracer that hunts unstable iron light up hidden tumors?
- Can a pill that starves tumors of oxygen help fight advanced cancer?
- New imaging agent aims to light up hidden tumors
- Can talking it out ease PTSD in cancer patients during a pandemic?
- Cancer care goes home: study tests nurse visits to cut hospital trips